SOPH insider (NASDAQ: SOPH) details planned stock and option-related sales
Rhea-AI Filing Summary
The filing for SOPH reports a planned sale of common stock by insider Jurgi Camblong. The notice lists 4,581 common shares to be sold following an exercise of stock options dated July 20, 2026, and an additional 19,800 founder shares dated March 18, 2021.
The sales are arranged through Morgan Stanley Smith Barney LLC Executive Financial Services and reference prior activity under a Rule 10b5-1 trading plan. Recent plan sales include 65,269 shares for $398,632.27 on June 30, 2026 and 50,069 shares for $290,329.01 on June 26, 2026, alongside multiple smaller transactions in May, June, and July 2026.
Positive
- None.
Negative
- None.
Key Figures
Shares from option exercise: 4,581 shares
Founder shares to be sold: 19,800 shares
10b5-1 sale on June 30, 2026: 65,269 shares for $398,632.27
+2 more
5 metrics
Shares from option exercise
4,581 shares
Common shares to be sold from Exercise of Stock Options dated July 20, 2026
Founder shares to be sold
19,800 shares
Founder shares of common stock dated March 18, 2021 included in planned sales
10b5-1 sale on June 30, 2026
65,269 shares for $398,632.27
Common stock sold as a 10b5-1 Sale for Jurgi Camblong
10b5-1 sale on June 26, 2026
50,069 shares for $290,329.01
Common stock sold under 10b5-1 trading plan for Jurgi Camblong
10b5-1 sale on July 10, 2026
8,500 shares for $47,791.25
Common stock 10b5-1 Sale for Jurgi Camblong
Key Terms
Form 144, Exercise of Stock Options, Founders Shares, 10b5-1 Sales
4 terms
Form 144 regulatory
"Filer Information | | | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
Exercise of Stock Options financial
"Common | 07/20/2026 | Exercise of Stock Options | Issuer"
10b5-1 Sales regulatory
"10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle"
10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stock sales does the SOPH Form 144 disclose?
The Form 144 for SOPH discloses a planned sale of 4,581 shares from an exercise of stock options and 19,800 founder shares, both in common stock, by insider Jurgi Camblong through a brokerage firm.
What recent 10b5-1 plan sales in SOPH stock are disclosed?
Recent Rule 10b5-1 sales include 65,269 shares for $398,632.27 on June 30, 2026 and 50,069 shares for $290,329.01 on June 26, 2026, along with several smaller trades in May, June, and July 2026.
Who is the broker handling the SOPH insider’s planned stock sales?
The planned SOPH stock sales are arranged through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.
Are the recent SOPH stock sales made under a trading plan?
Yes. The document describes multiple transactions as 10b5-1 Sales for Jurgi Camblong, indicating they were executed under a pre-arranged Rule 10b5-1 trading plan for SOPH common stock.